VitaNav is a life sciences company founded in 2018 with the goal of creating the next generation of commercially viable energy and neurohealth compounds.  The company’s first patent related to its development of D-beta hydroxybutyrate (D-BHB) products was granted in June 2021.

Its novel composition using D-BHB has a greater efficiency, better taste, and can be produced at a significantly lower cost than existing exogenous ketone products.  VitaNav’s D-BHB is made with renewable plant sugars using a proprietary carbon negative bio-fermentation process.

  • Consumer:

    Kenetik was launched by VitaNav as a direct-to-consumer ketone energy product in September 2021.

    For additional information or bulk purchase requests please email hello@drinkkenetik.com.

  • Licensing:

    Kenetik is currently the only product utilizing VitaNav’s novel compounds.

    For additional information on licensing please email partnerships@vitanav.net.

  • Medical/Research:

    VitaNav is actively engaged in multiple research studies using both consumer grade Kenetik and its concentrate forms. For questions or to request samples to please email research@vitanav.net.

  • Patent Portfolio:

    VitaNav maintains a comprehensive and robust patent portfolio for various aspects of its technologies including: